receptor-positive相关论文
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in
Objective:The recurrence or progression under endocrine therapy in hormone receptor-positive(HR+)advanced breast cancer(......
BACKGROUND Pathological complete response(pCR) is rare in hormone receptor-positive(HR+)HER2-negative breast cancer(BC) ......